These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24509957)

  • 21. Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation.
    Aristodemou P; Watt L; Baldwin C; Hugkulstone C
    Ophthalmic Plast Reconstr Surg; 2006; 22(2):134-6. PubMed ID: 16550061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face.
    Maas CS
    Facial Plast Surg Clin North Am; 2006 Aug; 14(3):241-5. PubMed ID: 16908391
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjunctive botulinum toxin type A: fillers and light-based therapies.
    Carruthers J; Carruthers A
    Int Ophthalmol Clin; 2005; 45(3):143-51. PubMed ID: 15970773
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuromodulators: available agents, physiology, and anatomy.
    Nettar K; Maas C
    Facial Plast Surg; 2011 Dec; 27(6):517-22. PubMed ID: 22205524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global 3-dimensional approach to natural rejuvenation: recommendations for perioral, nose, and ear rejuvenation.
    Gassia V; Raspaldo H; Niforos FR; Michaud T
    J Cosmet Dermatol; 2013 Jun; 12(2):123-36. PubMed ID: 23725306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapies in oculofacial rejuvenation.
    Bosniak S; Cantisano-Zilkha M; Purewal BK; Zdinak LA
    Orbit; 2006 Dec; 25(4):319-26. PubMed ID: 17182406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices.
    Carruthers J; Burgess C; Day D; Fabi SG; Goldie K; Kerscher M; Nikolis A; Pavicic T; Rho NK; Rzany B; Sattler G; Sattler S; Seo K; Werschler WP; Carruthers A
    Dermatol Surg; 2016 May; 42(5):586-97. PubMed ID: 27100962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum neurotoxin type A in facial aesthetics.
    De Boulle KL
    Expert Opin Pharmacother; 2007 Jun; 8(8):1059-72. PubMed ID: 17516871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin injections for facial rejuvenation].
    Société Française de Chirurgie Plastique Reconstructrice et Esthétique
    Ann Chir Plast Esthet; 2004 Oct; 49(5):553-6. PubMed ID: 15600009
    [No Abstract]   [Full Text] [Related]  

  • 30. Complications from toxins and fillers in the dermatology clinic: recognition, prevention, and treatment.
    Dayan SH
    Facial Plast Surg Clin North Am; 2013 Nov; 21(4):663-73. PubMed ID: 24200384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin: clinical techniques, applications, and complications.
    Stephan S; Wang TD
    Facial Plast Surg; 2011 Dec; 27(6):529-39. PubMed ID: 22205526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin rejuvenation without a scalpel. I. Fillers.
    Haneke E
    J Cosmet Dermatol; 2006 Jun; 5(2):157-67. PubMed ID: 17173591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.
    Carruthers JDA; Glogau RG; Blitzer A;
    Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers.
    Varga R
    Plast Surg Nurs; 2019; 39(4):119-124. PubMed ID: 31790040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cosmetic medicine: facial resurfacing and injectables.
    Nguyen AT; Ahmad J; Fagien S; Rohrich RJ
    Plast Reconstr Surg; 2012 Jan; 129(1):142e-153e. PubMed ID: 22186529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injectable Fillers in the Upper Face.
    Haiavy J; Elias H
    Atlas Oral Maxillofac Surg Clin North Am; 2016 Sep; 24(2):105-16. PubMed ID: 27499469
    [No Abstract]   [Full Text] [Related]  

  • 37. Lasers, fillers, and neurotoxins: avoiding complications in the cosmetic facial practice.
    Hassouneh B; Newman JP
    Facial Plast Surg Clin North Am; 2013 Nov; 21(4):585-98. PubMed ID: 24200377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporating Minimally Invasive Procedures into an Aesthetic Surgery Practice.
    Matarasso A; Nikfarjam J; Abramowitz L
    Clin Plast Surg; 2016 Jul; 43(3):449-57. PubMed ID: 27363759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic acid fillers on the horizon: roundtable discussion.
    Monheit G; Kestemont P; Sundaram H
    J Drugs Dermatol; 2012 Aug; 11(8):s26-8; discussion s28. PubMed ID: 22859225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.